SK287273B6 - N-Substituované diazabicyklické zlúčeniny, farmaceutický prípravok s ich obsahom a ich použitie - Google Patents
N-Substituované diazabicyklické zlúčeniny, farmaceutický prípravok s ich obsahom a ich použitie Download PDFInfo
- Publication number
- SK287273B6 SK287273B6 SK1681-2002A SK16812002A SK287273B6 SK 287273 B6 SK287273 B6 SK 287273B6 SK 16812002 A SK16812002 A SK 16812002A SK 287273 B6 SK287273 B6 SK 287273B6
- Authority
- SK
- Slovakia
- Prior art keywords
- pyridinyl
- diazabicyclo
- compound
- covalent bond
- pyrrole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55994300A | 2000-04-27 | 2000-04-27 | |
US09/833,914 US6809105B2 (en) | 2000-04-27 | 2001-04-12 | Diazabicyclic central nervous system active agents |
PCT/US2001/013798 WO2001081347A2 (fr) | 2000-04-27 | 2001-04-27 | Principes actifs diazabicycliques pour le systeme nerveux central |
Publications (2)
Publication Number | Publication Date |
---|---|
SK16812002A3 SK16812002A3 (sk) | 2003-04-01 |
SK287273B6 true SK287273B6 (sk) | 2010-05-07 |
Family
ID=27072208
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1681-2002A SK287273B6 (sk) | 2000-04-27 | 2001-04-27 | N-Substituované diazabicyklické zlúčeniny, farmaceutický prípravok s ich obsahom a ich použitie |
SK10-2010A SK287658B6 (sk) | 2000-04-27 | 2001-04-27 | N-substituované diazabicyklické zlúčeniny, farmaceutické kompozície s ich obsahom a ich použitie |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK10-2010A SK287658B6 (sk) | 2000-04-27 | 2001-04-27 | N-substituované diazabicyklické zlúčeniny, farmaceutické kompozície s ich obsahom a ich použitie |
Country Status (22)
Country | Link |
---|---|
EP (3) | EP2298775A1 (fr) |
JP (2) | JP4981232B2 (fr) |
KR (4) | KR100947187B1 (fr) |
CN (3) | CN100430398C (fr) |
AR (1) | AR030421A1 (fr) |
AU (2) | AU2001266559C1 (fr) |
BG (2) | BG66151B1 (fr) |
BR (1) | BR0107246A (fr) |
CA (2) | CA2683045A1 (fr) |
CZ (4) | CZ301324B6 (fr) |
HK (1) | HK1054375A1 (fr) |
HU (1) | HUP0300602A3 (fr) |
IL (3) | IL152231A0 (fr) |
MX (1) | MXPA02010594A (fr) |
MY (3) | MY145722A (fr) |
NO (1) | NO324250B1 (fr) |
NZ (1) | NZ521734A (fr) |
PE (1) | PE20011305A1 (fr) |
PL (2) | PL398491A1 (fr) |
SK (2) | SK287273B6 (fr) |
TW (4) | TWI323733B (fr) |
WO (1) | WO2001081347A2 (fr) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4078074B2 (ja) | 1999-12-10 | 2008-04-23 | ファイザー・プロダクツ・インク | ピロロ[2,3−d]ピリミジン化合物 |
SE0100326D0 (sv) * | 2001-02-02 | 2001-02-02 | Astrazeneca Ab | New compounds |
PL377791A1 (pl) | 2002-11-21 | 2006-02-20 | Pfizer Products Inc. | Pochodne 3-aminopiperydyny i sposoby ich wytwarzania |
US20050261348A1 (en) * | 2004-05-21 | 2005-11-24 | Buckley Michael J | (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent |
US7354937B2 (en) | 2004-05-21 | 2008-04-08 | Abbott Laboratories | (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane |
US20040242641A1 (en) * | 2003-05-27 | 2004-12-02 | Buckley Michael J. | (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent |
US20050043407A1 (en) * | 2003-08-22 | 2005-02-24 | Pfizer Inc | Pharmaceutical composition for the prevention and treatment of addiction in a mammal |
US7399765B2 (en) | 2003-09-19 | 2008-07-15 | Abbott Laboratories | Substituted diazabicycloalkane derivatives |
US20050065178A1 (en) * | 2003-09-19 | 2005-03-24 | Anwer Basha | Substituted diazabicycloakane derivatives |
GB0322140D0 (en) * | 2003-09-22 | 2003-10-22 | Pfizer Ltd | Combinations |
US8580842B2 (en) | 2003-09-30 | 2013-11-12 | Abbott Gmbh & Co. Kg | Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
US20050171079A1 (en) | 2004-02-04 | 2005-08-04 | Schrimpf Michael R. | Amino-substituted tricyclic derivatives and methods of use |
MXPA06012595A (es) | 2004-04-29 | 2007-05-09 | Abbott Lab | Analogos de amino-tetrazoles y metodos de uso. |
US7351833B2 (en) | 2004-07-23 | 2008-04-01 | Abbott Laboratories | (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate |
ES2391472T3 (es) * | 2005-12-20 | 2012-11-27 | Astrazeneca Ab | Derivados de cinnolina sustituidos como moduladores del receptor de GABAA y método para su síntesis |
US20070184490A1 (en) * | 2006-01-17 | 2007-08-09 | Marleen Verlinden | Neuronal nicotinic receptor ligands and their use |
US7728031B2 (en) | 2006-02-24 | 2010-06-01 | Abbott Laboratories | Octahydro-pyrrolo[3,4-b]pyrrole derivatives |
WO2008028903A2 (fr) | 2006-09-04 | 2008-03-13 | Neurosearch A/S | Compositions pharmaceutiques |
US20080167286A1 (en) | 2006-12-12 | 2008-07-10 | Abbott Laboratories | Pharmaceutical compositions and their methods of use |
US8486979B2 (en) | 2006-12-12 | 2013-07-16 | Abbvie Inc. | 1,2,4 oxadiazole compounds and methods of use thereof |
US8076350B2 (en) | 2006-12-22 | 2011-12-13 | Abbott Laboratories | Spirocyclic azaadamantane derivatives and methods of use |
UY30846A1 (es) | 2006-12-30 | 2008-07-31 | Abbott Gmbh & Amp | Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos |
JP5566698B2 (ja) | 2007-03-23 | 2014-08-06 | アッヴィ・インコーポレイテッド | アザアダマンタンエステルおよびカーバメート誘導体ならびにそれらの使用方法 |
CA2691782A1 (fr) | 2007-09-11 | 2009-03-19 | Abbott Laboratories | N-oxydes d'octahydro-pyrrolo[3,4-b]pyrrole |
PA8802501A1 (es) | 2007-10-31 | 2009-06-23 | Janssen Pharmaceutica Nv | Diaminas en puente o fusionadas sustituidas con arilo como moduladores de leucotrieno, hidrolasa |
MX2010005650A (es) * | 2007-11-21 | 2010-06-02 | Abbott Lab | Derivados de diazabicicloalcano substituidos con biarilo. |
US8703774B2 (en) | 2007-12-07 | 2014-04-22 | AbbVie Deutschland GmbH & Co. KG | Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases |
CN102026995B (zh) | 2007-12-07 | 2014-10-29 | Abbvie德国有限责任两合公司 | 5,6-二取代的羟吲哚衍生物和其用途 |
MX2010006202A (es) | 2007-12-07 | 2011-03-04 | Abbott Gmbh & Co Kg | Derivados de oxindol substituidos por amidometil y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. |
JP5595926B2 (ja) | 2007-12-07 | 2014-09-24 | アボット ゲーエムベーハー ウント カンパニー カーゲー | 5−ハロゲン−置換オキシインドール誘導体およびバソプレッシン依存性疾患の治療へのこれらの使用 |
MX2010006111A (es) | 2007-12-18 | 2010-06-25 | Actelion Pharmaceuticals Ltd | Derivados de 5-aminociclilmetil-oxazolidin-2-ona y su uso como antibacteriales. |
WO2009126806A2 (fr) | 2008-04-11 | 2009-10-15 | Janssen Pharmaceutica Nv | Amines de thiazolopyridin-2-yloxy-phenyl et de thiazolopyrazin-2-yloxy-phenyl en tant que modulateurs de leukotriene a4 hydrolase |
US8148408B2 (en) * | 2008-05-09 | 2012-04-03 | Abbott Laboratories | Selective substituted pyridine ligands for neuronal nicotinic receptors |
CA2755810A1 (fr) * | 2009-03-24 | 2010-09-30 | Msd K.K. | Nouveaux derives d'aminopyridine presentant une action inhibitrice selective de l'aurora a |
EP2430019B1 (fr) | 2009-05-14 | 2013-09-18 | Janssen Pharmaceutica, N.V. | Composes comprenant deux restes hétéroaryle bicycliques en tant que modulateurs de leukotriene a4 hydrolase |
WO2010138600A2 (fr) | 2009-05-29 | 2010-12-02 | Abbott Laboratories | Compositions pharmaceutiques utilisées dans le traitement de la douleur |
US8268853B2 (en) | 2009-06-25 | 2012-09-18 | Abbott Laboratories | 3,9-diazaspiro[5,5]undecane amides and ureas and methods of use thereof |
ES2711936T3 (es) | 2009-09-04 | 2019-05-08 | Biogen Ma Inc | Inhibidores de la tirosina cinasa de Bruton |
JP5847087B2 (ja) * | 2009-10-23 | 2016-01-20 | ヤンセン ファーマシューティカ エヌ.ベー. | オレキシン受容体調節因子としての縮合複素環式化合物 |
KR101859400B1 (ko) | 2009-10-23 | 2018-05-18 | 얀센 파마슈티카 엔.브이. | 오렉신 수용체 조절제로서의 이치환된 옥타하이드로피롤로[3,4-c]피롤 |
US9062044B2 (en) * | 2009-10-23 | 2015-06-23 | Janssen Pharmaceutica Nv | Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators |
US9586962B2 (en) | 2011-04-20 | 2017-03-07 | Janssen Pharmaceutica Nv | Disubstituted octahydropyrrolo [3,4-C] pyrroles as orexin receptor modulators |
AR091273A1 (es) | 2012-06-08 | 2015-01-21 | Biogen Idec Inc | Inhibidores de pirimidinil tirosina quinasa |
KR101655787B1 (ko) | 2014-05-08 | 2016-09-22 | 대우조선해양 주식회사 | 선박의 하이브리드 공기조화시스템 및 그 방법, 그리고 이를 포함하는 선박 또는 해양구조물 |
KR20160021679A (ko) | 2014-08-18 | 2016-02-26 | 대우조선해양 주식회사 | 극저온 환경의 장비용 히팅장치 및 방법 그리고 이를 구비하는 선박 |
KR20170090422A (ko) | 2014-10-31 | 2017-08-07 | 인디비어 유케이 리미티드 | 도파민 d3 수용체 길항제 화합물 |
LT3426251T (lt) | 2016-03-10 | 2022-06-27 | Janssen Pharmaceutica Nv | Depresijos gydymo būdai, panaudojant oreksino-2 receptoriaus antagonistus |
AU2017298035B2 (en) | 2016-07-21 | 2021-10-28 | Biogen Ma Inc. | Succinate forms and compositions of Bruton's tyrosine kinase inhibitors |
EP3686196A4 (fr) * | 2017-09-20 | 2021-03-31 | Hangzhou Innogate Pharma Co., Ltd. | Composé polycyclique agissant en tant qu'inhibiteur de l'ido et/ou en tant qu'inhibiteur double de l'ido-hdac |
CR20210240A (es) | 2018-11-14 | 2021-06-08 | Janssen Pharmaceutica Nv | Métodos sintéticos mejorados para elaborar compuestos heterocíclicos fusionados como moduladores del receptor de orexina |
WO2020239073A1 (fr) * | 2019-05-30 | 2020-12-03 | 中国科学院上海药物研究所 | Composé cyclique fusionné, son procédé de préparation et son utilisation |
CN112047878B (zh) * | 2020-10-15 | 2022-04-19 | 郑州猫眼农业科技有限公司 | 4-溴-6-氯吡啶-2-羧酸的制备方法 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0393424B1 (fr) * | 1989-04-17 | 1995-09-27 | Bayer Ag | Procédé de préparation de 2,7-Diazabicyclo(3.3.O)octanes |
NL9201810A (nl) | 1992-10-19 | 1994-05-16 | Dsm Nv | Werkwijze voor de omzetting van een olefine of een olefinemengsel. |
CA2112165C (fr) | 1992-12-25 | 2003-04-08 | Makoto Takemura | Derives amine bicycliques |
US5817679A (en) * | 1993-04-01 | 1998-10-06 | University Of Virginia | 7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands |
US5478939A (en) * | 1994-07-20 | 1995-12-26 | American Cyanamid Company | (R,R) and (S,S) 2,5-diazabicyclo [2,2,1]heptane derivatives |
US5472958A (en) | 1994-08-29 | 1995-12-05 | Abbott Laboratories | 2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function |
US5585388A (en) | 1995-04-07 | 1996-12-17 | Sibia Neurosciences, Inc. | Substituted pyridines useful as modulators of acetylcholine receptors |
JP4176147B2 (ja) * | 1995-07-28 | 2008-11-05 | アボツト・ラボラトリーズ | 化学的シナプス伝達の制御に有用なフロピリジン、チエノピリジン、ピロロピリジンおよび関連するピリミジン、ピリダジンおよびトリアジン化合物 |
GB9519558D0 (en) * | 1995-09-26 | 1995-11-29 | Merck Sharp & Dohme | Therapeutic agents |
JPH09172344A (ja) | 1995-12-19 | 1997-06-30 | Murata Mfg Co Ltd | 圧電共振子 |
US5733912A (en) | 1997-02-19 | 1998-03-31 | Abbott Laboratories | 7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission |
CA2289574C (fr) * | 1997-05-30 | 2007-04-24 | Neurosearch A/S | Derives de 8-azabicyclo[3.2.1]oct-2-ene et -octane utilises comme ligands cholinergiques de recepteurs nicotiniques de l'ach |
CA2289570C (fr) * | 1997-05-30 | 2007-04-03 | Neurosearch A/S | Derives de 9-azabicyclo(3.3.1)non-2-ene et nonane utilises comme ligands cholinergiques de recepteurs nicotiniques de l'ach. |
GB9722343D0 (en) * | 1997-10-22 | 1997-12-17 | British Telecomm | Distributed virtual environment |
ATE491689T1 (de) * | 1997-10-27 | 2011-01-15 | Neurosearch As | Heteroaryl diazacycloalkane als cholinergische ligande für nikotin-acetylcholin-rezeptoren |
US6632823B1 (en) * | 1997-12-22 | 2003-10-14 | Merck & Co., Inc. | Substituted pyridine compounds useful as modulators of acetylcholine receptors |
DE69907894T2 (de) * | 1998-04-02 | 2004-03-11 | Targacept, Inc. | Azatricyclo[3.3.1.1]decanderivate und diese enthaltende phrmazeutische zubereitungen |
PA8474101A1 (es) * | 1998-06-19 | 2000-09-29 | Pfizer Prod Inc | Compuestos de pirrolo [2,3-d] pirimidina |
JP2000026408A (ja) | 1998-07-02 | 2000-01-25 | Dai Ichi Seiyaku Co Ltd | 対掌体的に純粋なピロリジン誘導体、その塩、それらの製造方法 |
US6804251B1 (en) | 1998-11-12 | 2004-10-12 | Broadcom Corporation | System and method for multiplexing data from multiple sources |
FR2786769B1 (fr) * | 1998-12-04 | 2002-10-25 | Synthelabo | Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique |
DE60038823D1 (de) * | 1999-01-29 | 2008-06-19 | Abbott Lab | Diazabicycloderivate als Nikotin-Acetylcholin-Rezeptorliganden |
CN1210277C (zh) * | 1999-05-04 | 2005-07-13 | 神经研究公司 | 杂芳基二氮杂双环烷烃及其制备方法和应用 |
CN1192028C (zh) * | 1999-05-21 | 2005-03-09 | 艾博特公司 | 用作中枢神经系统药物的杂环取代的氨基氮杂环 |
US6815438B2 (en) * | 1999-12-14 | 2004-11-09 | Neurosearch A/S | Heteroaryl-diazabicycloalkanes |
-
2001
- 2001-04-26 MY MYPI20055633A patent/MY145722A/en unknown
- 2001-04-26 MY MYPI20011984A patent/MY137020A/en unknown
- 2001-04-27 CN CNB018117112A patent/CN100430398C/zh not_active Expired - Fee Related
- 2001-04-27 KR KR1020097010331A patent/KR100947187B1/ko not_active IP Right Cessation
- 2001-04-27 WO PCT/US2001/013798 patent/WO2001081347A2/fr active Application Filing
- 2001-04-27 CA CA002683045A patent/CA2683045A1/fr not_active Abandoned
- 2001-04-27 MX MXPA02010594A patent/MXPA02010594A/es active IP Right Grant
- 2001-04-27 EP EP10177450A patent/EP2298775A1/fr not_active Withdrawn
- 2001-04-27 CN CN2010102450796A patent/CN101935322A/zh active Pending
- 2001-04-27 KR KR1020027014385A patent/KR100899950B1/ko not_active IP Right Cessation
- 2001-04-27 SK SK1681-2002A patent/SK287273B6/sk not_active IP Right Cessation
- 2001-04-27 CZ CZ20023765A patent/CZ301324B6/cs not_active IP Right Cessation
- 2001-04-27 NZ NZ521734A patent/NZ521734A/en not_active IP Right Cessation
- 2001-04-27 KR KR1020097021390A patent/KR100947188B1/ko not_active IP Right Cessation
- 2001-04-27 CZ CZ20080677A patent/CZ302072B6/cs not_active IP Right Cessation
- 2001-04-27 IL IL15223101A patent/IL152231A0/xx not_active IP Right Cessation
- 2001-04-27 AU AU2001266559A patent/AU2001266559C1/en not_active Ceased
- 2001-04-27 EP EP10177411A patent/EP2295437A1/fr not_active Withdrawn
- 2001-04-27 EP EP01944118A patent/EP1284976A2/fr not_active Withdrawn
- 2001-04-27 AU AU6655901A patent/AU6655901A/xx active Pending
- 2001-04-27 PL PL398491A patent/PL398491A1/pl unknown
- 2001-04-27 AR ARP010101990A patent/AR030421A1/es active IP Right Grant
- 2001-04-27 PL PL01358340A patent/PL358340A1/xx unknown
- 2001-04-27 SK SK10-2010A patent/SK287658B6/sk not_active IP Right Cessation
- 2001-04-27 PE PE2001000385A patent/PE20011305A1/es not_active Application Discontinuation
- 2001-04-27 JP JP2001578437A patent/JP4981232B2/ja not_active Expired - Fee Related
- 2001-04-27 BR BR0107246-3A patent/BR0107246A/pt not_active IP Right Cessation
- 2001-04-27 KR KR1020087031655A patent/KR100961406B1/ko not_active IP Right Cessation
- 2001-04-27 HU HU0300602A patent/HUP0300602A3/hu unknown
- 2001-04-27 CZ CZ20090553A patent/CZ302038B6/cs not_active IP Right Cessation
- 2001-04-27 CA CA002407094A patent/CA2407094C/fr not_active Expired - Fee Related
- 2001-04-27 CN CN2012103509141A patent/CN102863441A/zh active Pending
- 2001-04-27 CZ CZ20100538A patent/CZ302795B6/cs not_active IP Right Cessation
- 2001-05-22 TW TW095100404A patent/TWI323733B/zh not_active IP Right Cessation
- 2001-05-22 TW TW090110172A patent/TWI311137B/zh not_active IP Right Cessation
- 2001-05-22 TW TW097145362A patent/TWI357903B/zh not_active IP Right Cessation
- 2001-05-22 TW TW100130949A patent/TW201141871A/zh unknown
-
2002
- 2002-10-24 NO NO20025107A patent/NO324250B1/no not_active IP Right Cessation
- 2002-11-21 BG BG107303A patent/BG66151B1/bg unknown
-
2003
- 2003-07-08 HK HK03104885.7A patent/HK1054375A1/zh unknown
-
2005
- 2005-03-07 MY MYPI20094589A patent/MY168244A/en unknown
-
2006
- 2006-08-06 IL IL177316A patent/IL177316A/en not_active IP Right Cessation
-
2009
- 2009-12-29 IL IL203035A patent/IL203035A/en not_active IP Right Cessation
-
2010
- 2010-03-17 BG BG110620A patent/BG110620A/bg unknown
-
2011
- 2011-09-15 JP JP2011202172A patent/JP2012041349A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8119635B2 (en) | Diazabicyclic central nervous system active agents | |
CA2407094C (fr) | Principes actifs diazabicycliques pour le systeme nerveux central | |
AU2001266559A1 (en) | Diazabicyclic central nervous system active agents | |
AU773795B2 (en) | Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20140427 |